Protagenic Therapeutics exec chair Garo H. Armen acquires 5,000 common shares for $1,294

PUBT · 2d ago
Protagenic Therapeutics exec chair Garo H. Armen acquires 5,000 common shares for $1,294
  • Garo H. Armen, executive chair and principal officer of Protagenic Therapeutics, bought 5,000 common shares.
  • Purchase price was $0.26 per share.
  • Armen’s direct holding rose to 31,294 common shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protagenic Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-036442), on August 06, 2026, and is solely responsible for the information contained therein.